WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006082046) USE OF S-CLENBUTEROL
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/082046    International Application No.:    PCT/EP2006/000890
Publication Date: 10.08.2006 International Filing Date: 01.02.2006
IPC:
A61K 31/137 (2006.01), A61P 25/28 (2006.01)
Applicants: EUCRO EUROPEAN CONTRACT RESEARCH GMBH & CO. KG [DE/DE]; Stresemannallee 6, 41460 Neuss (DE) (For All Designated States Except US).
GREB, Wolfgang [DE/DE]; (DE) (For US Only).
KRIEGLSTEIN, Josef [DE/DE]; (DE) (For US Only).
CULMSEE, Carsten [DE/DE]; (DE) (For US Only)
Inventors: GREB, Wolfgang; (DE).
KRIEGLSTEIN, Josef; (DE).
CULMSEE, Carsten; (DE)
Agent: CHRISTOPHERSEN & PARTNER; Patent Attorneys, Feldstrasse 73, 40479 Düsseldorf (DE)
Priority Data:
05002126.0 02.02.2005 EP
Title (EN) USE OF S-CLENBUTEROL
(FR) UTILISATION DE S-CLENBUTEROL
Abstract: front page image
(EN)The use of S-Clenbuterol for restoring and/or maintaining the function of partially or completely damaged/degenerated cells in the central nervous system and/or other nerve cells is claimed. The use of S-Clenbuterol leads to activation of astrocytes and initiation of endogenous processes of neuroprotection, it thus being possible for the damage or destruction of nerve cells to be reduced and, in some cases, even prevented.
(FR)L'invention concerne l'utilisation de S-clenbutérol pour restaurer et/ou maintenir la fonction de cellules partiellement ou totalement endommagées/dégénérées dans le système nerveux central et/ou d'autres cellules nerveuses. L'utilisation de S-clenbutérol entraîne l'activation d'astrocytes et le déclenchement de processus endogènes de neuroprotection, ce qui permet de réduire, voire dans certains cas d'empêcher l'endommagement ou la destruction des cellules nerveuses.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)